The ability to modify animal genomes rapidly at a specific locus would be valuable both for research purposes and in the development of animals suitable for xenotransplantation. In a proof-of-concept study, we used a unique, homologydependent strand transferase protein called drosophila recombination-associated protein (DRAP) and DNA oligonucleotides to modify the porcine gene encoding alpha 1,3 galactosyl transferase (GGTA1). This gene is responsible for generating xenotransplantation antigens resulting in hyperacute rejection. Pronuclear injection of DRAP and mutant oligonucleotides yielded piglets with heritable, modified alleles of GGTA1 in a direct, rapid and efficient manner. Cells derived from these piglets had markedly reduced alpha 1,3 galactosyl sugar epitopes. The simplicity of this method should permit rapid sequential or simultaneous modification of the various genes encoding or producing antigens that impose limits on xenotransplantation as they are discovered.
O ne limitation to using pigs for xenotransplantation in humans has been the strong immune response to porcine antigens. The most immunogenic epitopes, generated by alpha 1,3 galactosyl transferase (GGTA1; E.C. 2.4.1.151), are responsible for hyperacute rejection (1, 2) . GGTA1-null pigs were developed through the selection of rare GGTA1-null somatic cells generated by homologous recombination followed by complex nuclear transfer methods (3, 4) . The removal of the GGTA1-dependent antigens has uncovered other strong antigens that still impose barriers to xenotransplantation (5, 6) . The genes responsible for these antigens will need to be modified.
The approach that was successful for GGTA1 will be impractical if multiple, independent selection methods are required. To overcome these limitations we developed a method utilizing a protein called Drosophila recombinationassociated protein (DRAP) with homology-dependent strand transferase and topoisomerase activities (7, 8) . In a proof-ofconcept study, we generated piglets with heritable, modified GGTA1 alleles through pronuclear coinjection of DRAP and DNA oligonucleotides.
Recombinant DRAP (60 ng/ul), with an N-terminal (His 6 ), was expressed in bacteria and purified by Ni-NTA, Phosphocellulose and Superose 12 chromatography (8).
Oligonucleotides with 5Ј-OH ends (Invitrogen; HPLCpurified) were used for microinjection with DRAP singly, annealed as duplexes, or in non-complementary combinations: Oligonucleotides were suspended in sterile microinjection buffer (10 mM Tris-HCl, 10 mM NaCl, 1.0 mM MgCl 2 , and 0.1 mM EDTA, pH 7.5) to a final concentration of 75 ng/l. For microinjection of single oligonucleotide-DRAP complexes into zygotes, 1 l of 5ЈC, 3ЈNC, 5ЈC2, or 3ЈNC2 oligonucleotides (75g/l) and 1 l of DRAP (1.5 mg/ml) were diluted into 98 l microinjection buffer and incubated on ice for 30 min prior to injection (9) .
Ear notch-derived fibroblasts were collected from 100-mm culture dishes maintained at less than 60% confluence. For controls, a porcine fibroblast cell line from a commercial breed (ϩ/ϩ) and SK-N-DZ human neuroblastoma (Ϫ/Ϫ) cell line were used. Cells were trypsinized for two to three min, transferred to media, pelleted, washed 1ϫ with phosphate-buffered saline solution, pelleted and resuspended in 4.0% paraformaldehyde and incubated at room temperature for 10 min. Fixed cells were pelleted, washed two times with 0.4% BSA, and divided into two aliquots for fluorescein isothiocyanate conjugated isolectin 4 (FITC-IB4) labeling and for unlabeled, autofluorescence measurements. Cells for labeling were resuspended in 0.5 g/ml FITC-IB4, incubated in the dark at 37°C for 30 min., and washed two times with 0.4% body surface area (BSA). Both labeled and unlabeled cells were re-suspended in 400 l 0.4% BSA prior to flow cytometry. The raw adjusted geometric mean (AGM) fluorescence was calculated for each cell line by dividing the geometric mean fluorescence of the labeled cells to that of the nonlabeled cells, thus correcting for cell line autofluorescence (10) .
The oligonucleotides (31-mers; Table 1 legend) corresponded to the catalytic domain in exon 9 of GGTA1 (11) . Each oligonucleotide contained a central point mutation. Preliminary in vitro biochemical studies and exploratory studies in mice suggested a point mutation traps the transferred oligonucleotide and yields altered phenotypes (8) .
Semen for in vitro fertilization (IVF) was obtained from three Yorkshire males. Oocytes were collected from ovaries of undefined commercial breeds and matured in vitro. Approximately 50 zygotes 21 to 22 hr after insemination were visually sorted for the presence of two pronuclei whereupon DRAP and DNA were injected into the male pronucleus. Embryos at various stages of development were surgically transferred into uteri of asynchronous recipients. Recipient females (parity 0 or 1) were selected that exhibited first standing estrus 24 hr prior to oocyte insemination. Embryos that were cultured less than 48 hrs (1-2 cell stage) were placed in the ampullar region of the oviduct. Embryos cultured 48 hr or more (Ն4 cell stage) were placed in the tip of the uterine horn. Typically, 30 -70 injected embryos were placed in the oviduct. The pronuclear injection of DRAP and oligonucleotides showed no untoward effects on the establishment of IVF pregnancies or on litter size (9) . From 15 successful pregnancies a total of 96 live-born piglets were delivered (Table 1) .
Fibroblasts were obtained for culture from collagendigested ear notches of each offspring. The amount of alpha 1,3 galactosyl sugar residues on the fibroblast cell surface was determined by staining with FITC-labeled isolectin B4 (FITC-IB4) and quantified by flow cytometry of 10,000 cells. The AGM for each experimental cell line was normalized to the AGM obtained for the positive control line to correct for any run-to-run variability during each of the 15 separate flow studies carried out over a period of 18 months ( Table 1) .
The bimodal distribution of the normalized AGMs for all of the experimental cell lines (Fig. 1) Six F1 animals, developed from injections of DRAP and duplex oligonucleotide possessing 5Ј single stranded extensions and having among the lowest normalized AGMs, were bred. Three independent litters yielded a total of 22 healthy F2 piglets in one breeding cycle. Cultured ear notch fibroblasts of the F2 piglets were used to quantify FITC-IB4 staining of alpha 1,3 galactosyl epitopes. Furthermore, new fibroblast cultures were established from each of the F1 pigs to examine the stability of the reduced FITC-IB4 staining phenotype observed in the neonatal period. The reduction in FITC-IB4 staining is stable over the course of more than one year (not shown) and the reduced expression of alpha 1,3 galactosyl epitopes is heritable (Fig. 1) .
A majority of the F1 piglet cell lines had a normalized AGM less than half of the mean value for the positive control line. That is, less than what might be expected from the complete ablation of one active allele. This might occur if the animals were compound heterozygotes with the activity of the gene products from each allele being diminished relative to the activity of the wild-type allele. Heterozygosity was confirmed by sequencing. A 1.2 Kbp genomic fragment, corresponding to the This table summarizes the success of using DRAP and oligonucleotidedirected mutagenesis in the pig. DRAP injections had no untoward effects on litter size or phenotypic features in the pigs. The coinjection procedure yields animals with efficiencies comparable to standard IVF. DRAP plus oligonucleotide injections were successful in reducing the amount of GGTA1-dependent alpha 1,3 galactosyl residues on porcine fibroblasts as determined by quantitative and specific binding of FITC-labeled isolectin B4 (FITC-IB4) to these epitopes during flow cytometry. The normalized AGM was significantly reduced for 6 of 7 oligonucleotide sets tested. GGTA1 coding portion of exon 9 (694 bp) along with several hundred bp of flanking sequence, was amplified by highfidelity polymerase chain reaction (PCR) and cloned from 25 cell lines having the most reduced FITC-IB4 staining as well as the reference control cell line. This analysis identified several single nucleotide polymorphisms (cSNPs) in the GGTA1 sequence as well as frequent and consistent nucleotide substitutions in the experimental lines. Mutations occurred downstream from the 3Ј end(s) of the mutagenic oligonucleotide(s). The different oligonucleotides produced very similar mutations within the gene and there appear to be preferred sequences for mutagenesis. The most prevalent mutation occurred at AGA/TCT followed by GTG/CAC triplets-although mutations did not occur at every such triplet-and other trinucleotides were modified (Fig. 1) .
Biallelic mutations occur. This is illustrated in the sequence data from pig 676 -the animal with the most reduced FITC-IB4 staining-generated from an injection of DRAP and a duplex oligonucleotide. Each allele shows unique substitutions as well as three common, defined, substitutions and a fourth, indeterminant nucleotide (n). The latter is likely to be the common C3 T cSNP that was identified. There are several silent mutations as well as mutations leading to nonconservative amino acid substitutions (Fig. 2) .
DRAP is encoded by a variant (T312G; ins603G) of a cDNA identified subsequently during the Drosophila genome project (NM_168011) having both strand transferase and topoisomerase activity. DRAP contains phosphotyrosine binding and pleckstrin homology domains associated with protein-protein interactions and/or signal transduction (12) . Neither domain predicts a role in homology-dependent strand transfer. However, DRAP has residues, appropriately spaced, consistent with the Asp-Asp-Glu (DDE) catalytic domain found in various site-specific recombinases and viral integrases (13) .
We hypothesized that if DRAP and a mutant oligonucleotide were introduced into a cell nucleus, homology-dependent strand transfer would occur (7, 14) . The DNA intermediate would need to be resolved, possibly by the topoisomerase activity inherent in DRAP (8) , and result in a recombinogenic DNA strand break (15) . Subsequent modifications in the gene could be brought about by the actions of endogenous DNA repair enzymes. No evidence of general genotoxicity such as altered fertility, cancer or anatomic abnormalities in F1 or F2 animals was seen.
The predominant mutations induced by DRAP and oligonucleotides in pigs are G/C3A/T transitions and T/A3G/C transversions. This bears a striking similarity to the single nucleotide mutations that arise during the somatic hypermutation phases of immunogobulin gene maturation and cellular defense against retroviral infection (16, 17) .
Mutations in AGA or GTG triplets define a repertoire of 36 possible codon changes that can potentially induce 17 silent, 3 conservative, and 16 nonconservative substitutions involving numerous amino acids. The extent to which the changes affect total gene product activity in a cell depend upon the specific modifications in each allele and the degree to which each is expressed. We anticipate that ongoing studies will lead to a more complete understanding of this mutagenic mechanism and refinements in the method, allowing for more precise mutagenesis or homologous recombination.
At present, the DRAP method offers two advantages over approaches producing a null allele-that of speed and the ability to create gene products with variable activity.
Furthermore, as there are no selection steps it should be possible to modify several genes simultaneously or in succession. This will be important in the production of pigs for xenotransplantation. FIGURE 2. Modifications in both GGTA1 alleles. Cell line 676 was derived from a male piglet generated from co-injection of DRAP with a mutant duplex oligonucleotide having 5Ј single strand extensions. This animal had the lowest FITC-IB4 flow cytometry staining among the males in that group. Multiple cSNPs are indicated by the letters beneath the reference nucleotide sequence in each of the two alleles. Each line represents one allele. Where these mutations yield changes, relative to the reference amino acid sequence, they are noted below the reference amino acid sequence. The numbers on the right refer to the nucleotide sequence from GenBank entry AF221517 (http://www.ncbi.nlm. nih.gov/entrez/viewer.fcgi?dbϭnucleotide&valϭ13517236). The highlighted trinucleotides are common cSNPs also identified in the wild-type cell line.
